Ceftaroline in the Treatment of Bone and Joint Infections

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
OsteomyelitisJoint Infections
Interventions
DRUG

Ceftaroline

The duration of treatment will vary based on type of infection (acute osteomyelitis or joint infection) and if MRSA positive or negative.

Trial Locations (1)

32806

Orlando Regional Medical Center, Orlando

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Forest Laboratories

INDUSTRY

lead

Orlando Health, Inc.

OTHER